Park Capital Management’s Eli Lilly LLY Stock Holding History

Park Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$481K	Sell	416 -73	-15%	-$86.1K	0.24%	67
2026 Q2	$586K	Buy	489 +8	+2%	+$8.17K	0.35%	54
2026 Q1	$442K	Sell	481 -3	-0.6%	-$3.04K	0.43%	35
2025 Q4	$520K	Buy	484 +4	+0.8%	+$3.82K	0.37%	55
2025 Q3	$366K	Buy	480 +11	+2%	+$8.19K	0.29%	57
2025 Q2	$365K	Buy	469 +10	+2%	+$7.77K	0.34%	55
2025 Q1	$379K	Buy	459 +32	+7%	+$26.6K	0.44%	37
2024 Q4	$329K	Buy	+427	New	+$354K	0.39%	43

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Park Capital Management's LLY Position: Q3 2026 in Review

Park Capital Management reduced its Eli Lilly (LLY) stake by 15% in Q3 2026, selling an estimated $86.1K and leaving 416 shares worth $481K. The position accounts for 0.24% of the portfolio, ranked #67.

Park Capital Management first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $586K in Q2 2026. 3,679 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Park Capital Management held 416 shares of Eli Lilly worth $481K as of Q3 2026.
Park Capital Management sold 73 Eli Lilly shares in Q3 2026, an estimated $86.1K.
Eli Lilly made up 0.24% of Park Capital Management's portfolio in Q3 2026, its #67 holding.
Park Capital Management first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
Park Capital Management's Eli Lilly position peaked at $586K in Q2 2026.
3,679 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Park Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.